Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

TKNZT. Rowe Price Active Crypto ETF

NYSE · CIK 0002089855
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC6221 Commodity Contracts Brokers & Dealers
FY end1231
XBRL facts56

Identity from submissions API

NameT. Rowe Price Active Crypto ETF
CIK0002089855
TickersTKNZ
ExchangesNYSE
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC6221 Commodity Contracts Brokers & Dealers
EIN394422405
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone410-345-2000
Website—
Investor website—
Owner org09 Crypto Assets
Flags—
Description—
Insider transactions (issuer)0
Insider transactions (owner)0

Former names

  • None listed.
Business address
1307 POINT STREET
BALTIMORE
MD
21231
MD
Mailing address
1307 POINT STREET
BALTIMORE
MD
21231
MD

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

70 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-19 FWP FREE WRITING PROSPECTUS 0001999371-26-025820 333-291007 261575767 34 254337
2026-11-12 FWP FREE WRITING PROSPECTUS 0001999371-26-025128 333-291007 261542678 34 219966
2026-11-10 424B3 424B3 0001193125-26-455398 333-291007 261540175 33 672603
2026-11-10 10-Q 10-Q 0001193125-26-454710 001-43363 261538724 34 2565231 1 1
2026-11-05 FWP FREE WRITING PROSPECTUS 0001999371-26-024526 333-291007 261525150 34 41675
2026-11-04 424B3 PROSPECTUS SUPPLEMENT 0001999371-26-024444 333-291007 261521041 33 70252
2026-11-04 FWP FREE WRITING PROSPECTUS 0001999371-26-024441 333-291007 261520972 34 8478
2026-10-28 FWP FREE WRITING PROSPECTUS 0001999371-26-023675 333-291007 261492596 34 51309
2026-10-22 FWP FREE WRITING PROSPECTUS 0001999371-26-023266 333-291007 261477470 34 1235373
2026-10-15 FWP FREE WRITING PROSPECTUS 0001999371-26-022857 333-291007 261463527 34 51256361
2026-10-08 FWP FREE WRITING PROSPECTUS 0001999371-26-022480 333-291007 261450120 34 841177
2026-10-08 FWP FREE WRITING PROSPECTUS 0001999371-26-022414 333-291007 261448468 34 1269345
2026-10-02 FWP FREE WRITING PROSPECTUS 0001999371-26-021930 333-291007 261434076 34 1212608
2026-09-25 FWP FREE WRITING PROSPECTUS 0001999371-26-021325 333-291007 261406555 34 7929
2026-09-16 FWP FREE WRITING PROSPECTUS 0001999371-26-020648 333-291007 261384046 34 3660206
2026-09-15 FWP FREE WRITING PROSPECTUS 0001999371-26-020547 333-291007 261380186 34 95628
2026-09-10 FWP FREE WRITING PROSPECTUS 0001999371-26-020331 333-291007 261371931 34 289252
2026-09-09 FWP FREE WRITING PROSPECTUS 0001999371-26-020196 333-291007 261367453 34 397264
2026-09-09 424B3 PROSPECTUS SUPPLEMENT 0001999371-26-020168 333-291007 261366719 33 65071
2026-09-02 FWP FREE WRITING PROSPECTUS 0001999371-26-019634 333-291007 261355852 34 20794
2026-08-31 FWP FREE WRITING PROSPECTUS 0001999371-26-019324 333-291007 261345169 34 35289
2026-08-12 FWP FREE WRITING PROSPECTUS 0001999371-26-017705 333-291007 261267460 34 137644
2026-08-11 FWP FREE WRITING PROSPECTUS 0001999371-26-017617 333-291007 261262337 34 11428023
2026-08-11 424B3 424B3 0001193125-26-342793 333-291007 261259858 33 286719
2026-08-10 10-Q 10-Q 0001193125-26-341871 001-43363 261257452 34 1484580 1 1
2026-08-04 FWP FREE WRITING PROSPECTUS 0001999371-26-016892 333-291007 261235934 34 13660541
2026-08-04 FWP FREE WRITING PROSPECTUS 0001999371-26-016877 333-291007 261235422 34 6072
2026-08-03 FWP FREE WRITING PROSPECTUS 0001999371-26-016793 333-291007 261231506 34 3327590
2026-08-03 FWP FREE WRITING PROSPECTUS 0001999371-26-016748 333-291007 261230648 34 10983
2026-07-31 FWP FREE WRITING PROSPECTUS 0001999371-26-016565 333-291007 261225604 34 13599
2026-07-30 FWP FREE WRITING PROSPECTUS 0001999371-26-016515 333-291007 261224085 34 9168
2026-07-30 FWP FREE WRITING PROSPECTUS 0001999371-26-016488 333-291007 261222695 34 34059
2026-07-30 FWP FREE WRITING PROSPECTUS 0001999371-26-016427 333-291007 261221700 34 863806
2026-07-30 FWP FREE WRITING PROSPECTUS 0001999371-26-016406 333-291007 261220544 34 8030
2026-07-29 FWP FREE WRITING PROSPECTUS 0001999371-26-016304 333-291007 261214191 34 482560
2026-07-27 FWP FREE WRITING PROSPECTUS 0001999371-26-016064 333-291007 261206477 34 9113518
2026-07-23 FWP FREE WRITING PROSPECTUS 0001999371-26-015688 333-291007 261196807 34 8294
2026-07-22 FWP FREE WRITING PROSPECTUS 0001999371-26-015579 333-291007 261193819 34 16976
2026-07-22 FWP FREE WRITING PROSPECTUS 0001999371-26-015576 333-291007 261193647 34 88345
2026-07-22 FWP FREE WRITING PROSPECTUS 0001999371-26-015542 333-291007 261192767 34 7293617
2026-07-20 FWP FREE WRITING PROSPECTUS 0001999371-26-015403 333-291007 261186435 34 97634
2026-07-17 FWP FREE WRITING PROSPECTUS 0001999371-26-015287 333-291007 261182533 34 65153
2026-07-16 FWP FREE WRITING PROSPECTUS 0001999371-26-015128 333-291007 261178906 34 1320196
2026-07-16 FWP FREE WRITING PROSPECTUS 0001999371-26-015126 333-291007 261178891 34 1068462
2026-07-15 FWP FREE WRITING PROSPECTUS 0001999371-26-015091 333-291007 261178005 34 31241
2026-07-15 424B3 PROSPECTUS SUPPLEMENT 0001999371-26-014984 333-291007 261175196 33 28484
2026-07-15 8-K CURRENT REPORT 1.01,9.01 0001999371-26-014983 001-43363 261175193 34 376709 1 1
2026-07-14 424B3 PROSPECTUS SUPPLEMENT 0001999371-26-014982 333-291007 261175190 33 83388
2026-07-14 CERT NYSE ARCA CERTIFICATION 0001143362-26-000255 001-43363 261175034 34 385539
2026-07-13 FWP FREE WRITING PROSPECTUS 0001999371-26-014794 333-291007 261170414 34 391197
2026-07-13 FWP FREE WRITING PROSPECTUS 0001999371-26-014792 333-291007 261170407 34 748680
2026-07-13 FWP FREE WRITING PROSPECTUS 0001999371-26-014788 333-291007 261170353 34 1537830
2026-07-13 FWP FREE WRITING PROSPECTUS 0001999371-26-014786 333-291007 261170333 34 1113442
2026-07-10 FWP FREE WRITING PROSPECTUS 0001999371-26-014723 333-291007 261168015 34 12315
2026-07-10 FWP FREE WRITING PROSPECTUS 0001999371-26-014704 333-291007 261167388 34 2739101
2026-07-10 FWP FREE WRITING PROSPECTUS 0001999371-26-014703 333-291007 261167385 34 124946
2026-07-10 FWP FREE WRITING PROSPECTUS 0001999371-26-014702 333-291007 261167370 34 82159
2026-07-10 FWP FREE WRITING PROSPECTUS 0001999371-26-014701 333-291007 261167358 34 692589
2026-07-10 FWP FREE WRITING PROSPECTUS 0001999371-26-014700 333-291007 261167351 34 971739
2026-07-10 FWP FREE WRITING PROSPECTUS 0001999371-26-014698 333-291007 261167346 34 1536429
2026-07-10 FWP FREE WRITING PROSPECTUS 0001999371-26-014697 333-291007 261167318 34 867486
2026-06-23 424B3 PROSPECTUS 0001999371-26-013250 333-291007 261109580 33 1148918
2026-06-22 8-A12B REGISTRATION/LISTING OF A CLASS OF SECURITIES 0001999371-26-013156 001-43363 261104911 34 13530
2026-06-18 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002059 333-291007 261104717 33 1695
2026-06-16 S-1/A AMENDMENT TO FORM S-1 0001999371-26-012919 333-291007 261094382 33 71100
2026-05-15 S-1/A AMENDMENT TO FORM S-1 0001999371-26-010860 333-291007 26985820 33 956471
2026-04-27 S-1/A AMENDMENT TO FORM S-1 0001999371-26-009120 333-291007 26898023 33 2448875
2026-03-16 S-1/A AMENDMENT TO FORM S-1 0001999371-26-005896 333-291007 26754994 33 917031
2026-02-11 S-1/A AMENDMENT TO FORM S-1 0001999371-26-003054 333-291007 26620295 33 896101
2025-10-22 S-1 FORM S-1 0001999371-25-015832 333-291007 251409138 33 1181758 1 1

Latest XBRL company facts

One latest value per concept from companyfacts (56 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 800,000 2026-11-02 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap Assets Assets USD 25.43M 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap AssetsNet Net Assets USD 25.42M 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap Cash Cash USD 5,000 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 5,000 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 5,000 2026-04-01 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 760,000 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 760,000 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap GrossInvestmentIncomeOperating Gross Investment Income, Operating USD 1,000 2026-04-01 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap IncreaseDecreaseInManagementFeePayable IncreaseDecreaseInManagementFeePayable USD 14,000 2026-04-01 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement USD 30,000 2026-04-01 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap InvestmentCompanyExpenseRatioExcludingIncentiveFee Investment Company, Expense Ratio Excluding Incentive Fee pure 0.009 2026-07-16 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap InvestmentCompanyExpenseRatioIncludingIncentiveFee Investment Company, Expense Ratio Including Incentive Fee pure 0.008 2026-07-16 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap InvestmentCompanyGainLossOnInvestmentPerShare Investment Company, Gain (Loss) on Investment, Per Share USD/shares 8.49 2026-07-16 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap InvestmentCompanyIncreaseDecreaseFromShareTransaction InvestmentCompanyIncreaseDecreaseFromShareTransaction USD 19.53M 2026-04-01 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap InvestmentCompanyInvestmentIncomeLossPerShare Investment Company, Investment Income (Loss), Per Share USD/shares -0.04 2026-07-16 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap InvestmentCompanyInvestmentIncomeLossRatio Investment Company, Investment Income (Loss) Ratio pure -0.007 2026-07-16 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap InvestmentCompanyManagementFeeWaived InvestmentCompanyManagementFeeWaived USD 6,000 2026-04-01 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease Investment Company, Net Asset Value Per Share, Period Increase (Decrease) USD/shares 8.45 2026-07-16 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap InvestmentCompanyTotalReturn Investment Company, Total Return pure 0.338 2026-07-16 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap InvestmentIncomeInvestmentExpense Investment Income, Investment Expense USD 36,000 2026-04-01 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap InvestmentIncomeNet Investment Income, Net USD 0 2026-04-01 2026-06-30 2026 Q1 10-Q 2026-08-10 0001193125-26-341871
us-gaap InvestmentOwnedAtCost Investment Owned, at Cost USD 19.72M 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap InvestmentOwnedAtFairValue Investment Owned, at Fair Value USD 25.43M 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap InvestmentOwnedPercentOfNetAssets Investment Owned, Percent of Net Assets pure 1 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap Investments Investments USD 0 2026-06-30 2026 Q1 10-Q 2026-08-10 0001193125-26-341871
us-gaap Liabilities Liabilities USD 14,000 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap ManagementFeeExpense Management Fee Expense USD 36,000 2026-04-01 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap ManagementFeePayable Management Fee Payable USD 14,000 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap NetAssetValuePerShare Net Asset Value Per Share USD/shares 33.45 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 19.53M 2026-04-01 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -19.52M 2026-04-01 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 5.89M 2026-04-01 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap NetInvestmentIncome Net Investment Income USD -29,000 2026-04-01 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap NonInvestmentAssetsLessNonInvestmentLiabilities Non Investment Assets Less Non Investment Liabilities USD -9,000 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets Non Investment Assets Less Non Investment Liabilities, Percent of Net Assets pure -0 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-04-01 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap PaymentsForPurchaseOfInvestmentOperatingActivity PaymentsForPurchaseOfInvestmentOperatingActivity USD 23.68M 2026-04-01 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 0 2026-04-01 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap ProceedsFromDispositionOfInvestmentOperatingActivity ProceedsFromDispositionOfInvestmentOperatingActivity USD 4.17M 2026-04-01 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 19.53M 2026-04-01 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 14.98M 2026-07-14 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap RealizedAndUnrealizedGainLossInvestmentAndDerivativeOperatingBeforeTax RealizedAndUnrealizedGainLossInvestmentAndDerivativeOperatingBeforeTax USD 5.92M 2026-04-01 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap RealizedGainLossInvestmentAndDerivativeOperatingBeforeTax RealizedGainLossInvestmentAndDerivativeOperatingBeforeTax USD 209,000 2026-04-01 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap RealizedInvestmentGainsLosses Realized Investment Gains (Losses) USD 0 2026-04-01 2026-06-30 2026 Q1 10-Q 2026-08-10 0001193125-26-341871
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 25 2026-07-14 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap SharesOutstanding Shares, Outstanding shares 760,000 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap StockholdersEquityPeriodIncreaseDecrease Stockholders' Equity, Period Increase (Decrease) USD 25.42M 2026-04-01 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 760,000 2026-04-01 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap StockIssuedDuringPeriodSharesPeriodIncreaseDecrease Stock Issued During Period, Shares, Period Increase (Decrease) shares 760,000 2026-04-01 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 19.53M 2026-04-01 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap StockRepurchasedDuringPeriodShares Stock Repurchased During Period, Shares shares 0 2026-04-01 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 0 2026-04-01 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap UnrealizedGainLossInvestmentAndDerivativeOperatingBeforeTax UnrealizedGainLossInvestmentAndDerivativeOperatingBeforeTax USD 5.71M 2026-04-01 2026-09-30 2026 Q2 10-Q 2026-11-10 0001193125-26-454710
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD 0 2026-04-01 2026-06-30 2026 Q1 10-Q 2026-08-10 0001193125-26-341871

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →